Jian Wu

Jian Wu

Auto-generated profile, based on publicly available information

Jian Wu

The Affiliated Hospital of Nanjing University of TCM, Jiangsu Province Hospital of TCM, Nanjing 210029, China

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2014 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
BLBao-Xin-Zi Liu
Bao-Xin-Zi Liu
JZJin-Yong Zhou
Jin-Yong Zhou
YLYu Li
Yu Li
ZXzou xi
zou xi
JWJian Wu
Jian Wu
RWRui-Ping Wang
Rui-Ping Wang
Colorectal cancer has become one of the leading cause of cancer morbidity and mortality throughout world. Hederagenin, a derivative of oleanolic acid isolated from the leaves of ivy (Hedera helix L.), has been shown to have potential anti-tumor activity. The study was conducted to evaluate whether hederagenin could induce apoptosis of human colon cancer LoVo cells and explore the possible mechanism. MTT assay was used for evaluating cell viability while Annexin V-FITC/PI assay and Hoechst 33342 nuclear stainining were used for the determination of apoptosis and mitochondrial membrane potential. DCFH-DA fluorescence staining and flow cytometry were used to measure ROS generation. Real-time PCR and western blot analysis were performed for apoptosis-related protein expressions. MTT assay showed that hederagenin could significantly inhibit the viability of LoVo cells in a concentration-dependent and time-dependent manner by IC50 of 1.39 μM at 24 h and 1.17 μM at 48 h. The apoptosis ratio was significantly increased to 32.46% and 81.78% by the induction of hederagenin (1 and 2 μM) in Annexin V-FITC/PI assay. Hederagenin could also induce the nuclear changes characteristic of apoptosis by Hoechst 33342 nuclear stainining under fluorescence microscopy. DCFH-DA fluorescence staining and flow cytometry showed that hederagenin could increase significantly ROS generation in LoVo cells. Real-time PCR showed that hederagenin induced the up-regulation of Bax and down-regulation of Bcl-2, Bcl-xL and Survivin. Western blotting analysis showed that hederagenin decreased the expressions of apoptosis-associated proteins Bcl-2, procaspase-9, procaspase-3, and polyADP- ribosepolymerase (PARP) were increased, while the expressions of Bax, caspase-3, caspase-9 were increased. However, there was no significant change on caspase-8. These results indicated that the disruption of mitochondrial membrane potential might contribute to the apoptosis of hederagenin in LoVo cells. Our findings suggested that hederagenin might be a promising therapeutic candidate for human colon cancer.

17 October 2013 in Molecules
Verified
Journal Article
Open access
PDF file
YLYu Li
Yu Li
JGJunfei Gu
Junfei Gu
ZXzou xi
zou xi
JWJian Wu
Jian Wu
MZMing-Hua Zhang
Ming-Hua Zhang
RWRui-ping Wang
Rui-ping Wang
P. polyphylla Smith var. chinensis (Franch.) Hara (PPSCFH) has been used as medicinal Paris for the prevention and treatment of cancers in China for thousands of years. Its main components, steroidal saponins (PRS), have been confirmed to inhibit tumor growth. In the present study, the immunostimulation of PRS was investigated in Lewis bearing-C57BL/6 mice while the induction of apoptosis in A549 cells was also studied. The treatment with PRS (2.5, 5.0 and 7.5 mg/kg) significantly inhibited tumor, volume, and weight in the C57BL/6 mice. The rates of inhibition of PRS (at 2.5, 5.0 and 7.5 mg/kg) were 26.49 ± 17.30%, 40.32 ± 18.91% and 54.94 ± 16.48%, respectively. The spleen and thymus indexes were increased remarkably, while the levels of inflammatory cytokines including TNF-α, IL-8 and IL-10 in serum were decreased according to ELISA assays. For A549 cells, Hoechst 33342 staining and annexin V/PI by flow cytometry showed that PRS (0.25, 0.50 and 0.75 mg/mL) induced nuclear changes of A549 cells with DNA condensation and fragmentations of chromatin, as well as inducing apoptosis. Furthermore, PRS could also attenuate the over-generation of intracellular ROS. Western blotting analysis showed a significant decrease on the expressions of proinflammatory cytokines MCP-1, IL-6 and TGF-β1, as well as cell adhesion molecule ICAM-1, by treatment with PRS. Our results demonstrated that the inhibition of PRS on tumor growth might be associated with the amelioration of inflammation responses, induction of apoptosis, as well as the decrease of ROS. These results suggested that PRS implied a potential therapeutic effect in the lung cancer treatment.

1 May 2019 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
JWJian Wu
Jian Wu
XZXing-Xing Zhang
Xing-Xing Zhang
ZXzou xi
zou xi
MWMin Wang
Min Wang
HWHong-Xing Wang
Hong-Xing Wang
SMSun qing Min
Sun qing Min

19 January 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
TWTing-Ting Wu
Ting-Ting Wu
JLJun Lu
Jun Lu
PZPei-Qiu Zheng
Pei-Qiu Zheng
SLShenlin Liu
Shenlin Liu
JWJian Wu
Jian Wu
ZXzou xi
zou xi
In the article titled “Yiqi Huayu Jiedu Decoction Inhibits the Invasion and Metastasis of Gastric Cancer Cells through TGF-β/Smad Pathway” [1], the clinical rationale for the study was not adequately supported because the statement that “Clinical study on large samples has shown that YHJD can obviously improve the quality of life of patients and prolong their survival” was unreferenced. The study was based on the outcomes of the project “Study on the individualized treatment based on Jianpi Yangwei for postoperative gastric cancer recurrence and metastasis (健脾养胃法为主的个体化治疗对胃癌术后复发转移干预方案的研究)” (200807022), which was funded by the National Administration of Traditional Chinese Medicine and ended in 2016. One of the authors, Dr. Liu, published a prospective cohort study on YHJD in gastric cancer in 2014 [2], updated in English in 2019 [3].